how long has tirzepatide been out vs. Retatrutide: Key Differences Explained Mounjaro (Tirzepatide) | Lifestyle Medical

The JAMA article mentioned above recognizes that during such situations the anesthesiologist and surgeon must take special precautions to avoid aspiration

5 People with diabetes were excluded

Expanding options for optimizing type 2 diabetes treatment As the treatment landscape for type 2 diabetes continues to evolve, the findings from the SURPASS-SWITCH trial offer timely insight for clinicians managing patients who are not achieving glycemic or weight-related goals with their current GLP-1 receptor agonist regimen

For example, individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use GLP-1 medications

[DOI] [PMC free article] [PubMed] 8.Ito, F., Sono, Y

Antioxidants, 10(1), 118